This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Duke University, The University of North Carolina at Chapel Hill. Active years: 2021.
Company Filing History:
1 out of 2,075 
1 out of 1,325 
Years Active: 2021
Title: Federico Innocenti: Innovator in Vascular Research
Introduction
Federico Innocenti is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of vascular research, particularly in understanding the effects of certain cancer treatments on patients.
Latest Patents
In his recent patent, titled "Methods of identifying risk of vascular endothelial growth factor (VEGF) pathway inhibitor-induced hypertension," Federico Innocenti has developed methods to identify subjects at risk of developing toxicities from the drug bevacizumab. This patent involves measuring nucleic acid or gene mutations in samples obtained from subjects, which can help in predicting adverse effects such as proteinuria and hypertension. He holds 1 patent in this area.
Career Highlights
Federico has worked at prestigious institutions, including the University of North Carolina at Chapel Hill and Duke University. His work has been instrumental in advancing the understanding of drug-induced side effects, which is crucial for improving patient care in oncology.
Collaborations
Throughout his career, Federico has collaborated with esteemed colleagues, including Kouros Owzar and Jin Wang. Their combined expertise has contributed to the development of innovative solutions in the medical field.
Conclusion
Federico Innocenti's work exemplifies the importance of innovation in medical research, particularly in identifying risks associated with cancer treatments. His contributions continue to impact the field positively.